Global Carotid Artery Stents Market Size, Share, and Industry Analysis – by Material Type, by Mode of Delivery, by Application, and by End-use – Growth and Trend Forecast, 2026 -2035

The carotid artery stents market size was estimated to be worth USD 574.85 million in 2025. The market is expected to expand at a compound annual growth rate (CAGR) of 4.6% from USD 596.63 million in 2026 to USD 896.02 million by 2035. The strong market growth is driven by increasing prevalence of carotid artery stenosis, higher incidence of stroke, advancements in stent technology, and rising adoption of minimally invasive endovascular procedures. Additionally, increased awareness of preventive cardiovascular care further fuels global market expansion.

Published: March 28, 2026
100 Pages

Market Overview

According to the American College of Cardiology, carotid artery stenting procedures are performed across more than 900 hospitals in the United States, highlighting the country’s well-established healthcare infrastructure and widespread clinical adoption.

The carotid artery stents market has experienced robust historical growth over the past decade, driven by advancements in stent design, drug-eluting technology, and procedural techniques. Companies like Medtronic and Abbott Laboratories have pioneered developments in open-cell, closed-cell, and hybrid stent designs. According to a 2023 NIH/NCBI report, carotid stenting procedures are increasingly replacing open surgery for eligible patients due to their safety, precision, and shorter hospitalization times.

The anticipated growth of the carotid artery stents market is fueled by rising prevalence of carotid artery disease, higher rate of ischemic stroke, and increasing use of minimally invasive endovascular procedures. Advancements in stent technology, including drug-eluting, bioresorbable, and hybrid designs, are further driving clinical adoption. According to recent industry reports, the market is projected to grow significantly through 2035, supported by expanding healthcare infrastructure in emerging economies, increasing patient awareness of stroke prevention, and the broader presence of global medical device companies in developing regions.

Carotid Artery Stents Market Overview

Base Year Market Size (2025): USD 574.85 Million

CAGR: 4.6%

Forecast Year Market Size (2035): USD 896.02 Million

Leading Region: North America

Emerging Countries: India, Brazil, China, Mexico, UAE

Major Players:

  • Medtronic

  • Abbott Laboratories

  • Boston Scientific

  • Terumo Corporation

  • Cordis

Carotid Artery Stents Market Trends

The global carotid artery stents market is witnessing a transformative phase driven by technological advancements and the increasing shift toward minimally invasive interventions.

· The development of drug-eluting, bioresorbable, and hybrid stents has enhanced procedural outcomes, reduced restenosis rates, and improved long-term vessel patency, providing safer and more efficient treatment options for patients with carotid artery disease.

· This technological advancement enhances procedural precision and patient safety while reducing recovery periods and hospital stays, making carotid artery stenting a more viable and preferred alternative to open surgery globally.

· Additionally, the rising use of imaging-guided and navigation-assisted stent delivery systems is transforming interventional procedures by enhancing precision, lowering complication risks, and improving overall clinical efficiency in hospitals and specialized cardiac facilities.

· Additionally, expansion into emerging markets with growing healthcare infrastructure, increasing stroke awareness, and rising adoption of minimally invasive procedures is reshaping regional market dynamics and creating substantial opportunities for manufacturers.

· This collaborative approach, including partnerships between stent manufacturers and hospitals or interventional cardiology centers, is enhancing clinical training, accelerating technology adoption, and improving patient outcomes globally.

Collectively, these advancements are expected to significantly propel market growth, foster innovation, and strengthen the global footprint of the carotid artery stents industry in the coming years.

Carotid Artery Stents Market Analysis

By Material Type

Metals dominate the carotid artery stents market due to their strength, biocompatibility, and long-term durability in vascular interventions.

Based on material type, the global carotid artery stents market is segmented into metals (stainless steel, nitinol, cobalt chromium, and others) and polymers. The metals segment led the market, with a market share of 96.28% in 2025.

By Mode of Delivery

Balloon-expandable stents dominate the market with precise lesion deployment and high procedural control.

Based on mode of delivery, the global carotid artery stents market is segmented into balloon-expandable and self-expanding stents. The balloon-expandable stents segment led the market, with a major market share in 2025.

By Application

Symptomatic carotid artery stenosis represents the largest application segment in the carotid artery stents market.

Based on application, the carotid artery stents market is segmented into symptomatic stenosis, asymptomatic stenosis, and post-CEA restenosis. The symptomatic carotid artery stenosis segment led the market, with a major market share in 2025.

By End-use

Hospitals dominate the carotid artery stents market with the highest adoption of procedures

Based on end-use, the carotid artery stents market is segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment led the market, with a major market share in 2025.

Regional Analysis

North America leads the global carotid artery stents market with advanced vascular intervention infrastructure and strong stroke prevention adoption.

North America held the largest share of 41.92% in the global carotid artery stents market.

Europe emerges as a strong contender advancing carotid stent adoption through clinical innovation and expanding vascular care networks.

Europe maintained the second position in the global carotid artery stents market, supported by strong healthcare systems, growing stroke awareness, and rising preference towards minimally invasive procedures.

Key Companies Profiled

The competitive landscape of the global carotid artery stents market is characterized by strong competition among established cardiovascular device manufacturers and emerging vascular intervention specialists. The leading key players in the industry such as Abbott, Boston Scientific, Medtronic, and Cordis collectively hold a major share in the market. The strong hold of these key players is supported by their advanced stent portfolios, continuous innovation in embolic protection systems, and strong hospital-based distribution networks. While other key players focus on expanding their neurovascular and peripheral intervention capabilities through strategic partnerships, product advancements, and regulatory approvals.

The market is also witnessing the growing presence of regional manufacturers and specialized vascular device companies offering cost-effective stenting solutions. Additionally, increasing investments in minimally invasive stroke prevention therapies and next-generation stent designs are intensifying competition, pushing companies to enhance procedural safety, improve clinical outcomes, and expand their global footprint.

Carotid Artery Stents Market Companies:

Several prominent players driving innovation and growth in the carotid artery stents industry are as follows:

  • Abbott Laboratories

  • AngioDynamics, Inc.

  • Balton Sp. z o.o.

  • Biotronik SE & Co. KG

  • Boston Scientific Corporation

  • Cardinal Health, Inc.

  • Cook Medical Inc.

  • Cordis

  • C.R. Bard, Inc.

  • DISA Vascular

  • Gore Medical (W. L. Gore & Associates, Inc.)

  • InspireMD, Inc.

  • Lifetech Scientific Corporation

  • Medtronic plc

  • Merit Medical Systems, Inc.

  • MicroPort Scientific Corporation

  • Optimed Medizinische Instrumente GmbH

  • Roxwood Medical, Inc.

Market Segmentation

This study provides revenue growth and emerging trends across global, regional, and country levels from 2021 to 2035, segmenting the Carotid Artery Stents Market by-

  • Material Type (Revenue in USD Million, 2021 - 2035)

    • Metals

      • Stainless Steel

      • Nitinol

      • Cobalt Chromium

      • Others

    • Polymers

  • Mode of Delivery (Revenue in USD Million, 2021 - 2035)

    • Balloon-expandable Stents

    • Self-expanding Stents

  • Application (Revenue in USD Million, 2021 - 2035)

    • Symptomatic Carotid Artery Stenosis

    • Asymptomatic Carotid Artery Stenosis

    • Post-CEA restenosis

  • End use (Revenue in USD Million, 2021 - 2035)

    • Hospitals

    • Ambulatory Surgical Centers

    • Others

  • Regional (Revenue in USD Million, 2021 - 2035)

    • North America

      • U.S.

      • Canada

    • Europe

      • U.K.

      • Germany

      • France

      • Italy

      • Spain

      • Denmark

      • Sweden

      • Norway

      • Switzerland

      • Netherlands

    • Asia Pacific

      • Japan

      • China

      • India

      • Australia

      • Thailand

      • South Korea

      • Indonesia

    • Latin America

      • Brazil

      • Mexico

      • Argentina

      • Colombia

    • Middle East and Africa

      • South Africa

      • Saudi Arabia

      • UAE

      • Kuwait

Table of Content

1. Methodology and Scope

1.1. Scope of the Study

1.1.1. Market Segmentation

1.1.2. Market Definition

1.1.3. Inclusions and Exclusions of the Study

1.2. Research Design

1.2.1. Base Year, Historical Data, and Forecast Period

1.2.2. Data Collection Methods

1.2.2.1. Secondary Sources

1.2.2.2. Primary Sources

1.2.3. Research Methodology

1.2.3.1. Base Year Calculation/ Parent Market Analysis, Company/ Brand Share Analysis, 2025 (Top-down Approach)

1.2.3.2. Volume-Price Approach (Bottom-up Approach)

1.2.3.3. Data Triangulation

1.2.4. Forecasting Model

1.3. Research Assumptions

1.4. Validation and Data Quality Control

1.5. List of Primary Sources

1.6. List of Secondary Sources

2. Executive Summary

2.1. Market Overview

2.2. Segment Snapshot

2.3. Competitive Landscape Snapshot

3. Industry Outlook

3.1. Industry Ecosystem Analysis

3.2. Parent/ Ancillary Market Analysis

3.3. Market Dynamics

3.3.1. Drivers

3.3.2. Restraints/ Challenges

3.3.3. Opportunities

3.4. Consumer Behaviour Analysis

3.5. Value Chain Analysis

3.6. Technology Roadmap

3.7. Porters Analysis

3.8. PESTLE Analysis

4. Market Estimates and Forecasts, By Material Type, 2021 - 2035 (Market Size in USD Mn, Volume in Absolute Number)

4.1. Metals

4.1.1. Stainless Steel

4.1.2. Nitinol

4.1.3. Cobalt Chromium

4.1.4. Others

4.2. Polymers

5. Market Estimates and Forecasts, By Mode of Delivery, 2021 – 2035 (USD Mn)

5.1. Balloon-expandable Stents

5.2. Self-expanding Stents

6. Market Estimates and Forecasts, By Application, 2021 – 2035 (USD Mn)

6.1. Symptomatic Carotid Artery Stenosis

6.2. Asymptomatic Carotid Artery Stenosis

6.3. Post-CEA restenosis

7. Market Estimates and Forecasts, By End use, 2021 – 2035 (USD Mn)

7.1. Hospitals

7.2. Ambulatory Surgical Centers

7.3. Others

8. Market Estimates and Forecasts, By Region, 2021 - 2035 (USD Mn)

8.1. North America

8.1.1. U.S.

8.1.1.1. U.S. Carotid Artery Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.1.1.2. Market Dynamics

8.1.1.3. Competitive Landscape

8.1.1.4. Regulatory Framework

8.1.1.5. Reimbursement Scenario

8.1.2. Canada

8.1.2.1. Canada Carotid Artery Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.1.2.2. Market Dynamics

8.1.2.3. Competitive Landscape

8.1.2.4. Regulatory Framework

8.1.2.5. Reimbursement Scenario

8.2. Europe

8.2.1. Germany

8.2.1.1. Germany Carotid Artery Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.2.1.2. Market Dynamics

8.2.1.3. Competitive Landscape

8.2.1.4. Regulatory Framework

8.2.2. Reimbursement Scenario

8.2.3. U.K.

8.2.3.1. UK Carotid Artery Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.2.3.2. Market Dynamics

8.2.3.3. Competitive Landscape

8.2.3.4. Regulatory Framework

8.2.3.5. Reimbursement Scenario

8.2.4. France

8.2.4.1. France Carotid Artery Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.2.4.2. Market Dynamics

8.2.4.3. Competitive Landscape

8.2.4.4. Regulatory Framework

8.2.4.5. Reimbursement Scenario

8.2.5. Italy

8.2.5.1. Italy Carotid Artery Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.2.5.2. Market Dynamics

8.2.5.3. Competitive Landscape

8.2.5.4. Regulatory Framework

8.2.5.5. Reimbursement Scenario

8.2.6. Spain

8.2.6.1. Spain Carotid Artery Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.2.6.2. Market Dynamics

8.2.6.3. Competitive Landscape

8.2.6.4. Regulatory Framework

8.2.6.5. Reimbursement Scenario

8.2.7. Sweden

8.2.7.1. Sweden Carotid Artery Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.2.7.2. Market Dynamics

8.2.7.3. Competitive Landscape

8.2.7.4. Regulatory Framework

8.2.7.5. Reimbursement Scenario

8.2.8. Norway

8.2.8.1. Norway Carotid Artery Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.2.8.2. Market Dynamics

8.2.8.3. Competitive Landscape

8.2.8.4. Regulatory Framework

8.2.8.5. Reimbursement Scenario

8.2.9. Denmark

8.2.9.1. Denmark Carotid Artery Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.2.9.2. Market Dynamics

8.2.9.3. Competitive Landscape

8.2.9.4. Regulatory Framework

8.2.9.5. Reimbursement Scenario

8.2.10. Switzerland

8.2.10.1. Switzerland Carotid Artery Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.2.10.2. Market Dynamics

8.2.10.3. Competitive Landscape

8.2.10.4. Regulatory Framework

8.2.10.5. Reimbursement Scenario

8.2.11. Netherlands

8.2.11.1. Netherlands Carotid Artery Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.2.11.2. Market Dynamics

8.2.11.3. Competitive Landscape

8.2.11.4. Regulatory Framework

8.2.11.5. Reimbursement Scenario

8.2.12. Rest of Europe

8.2.12.1. Rest of Europe Carotid Artery Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.2.12.2. Market Dynamics

8.2.12.3. Competitive Landscape

8.2.12.4. Regulatory Framework

8.2.12.5. Reimbursement Scenario

8.3. Asia Pacific

8.3.1. China

8.3.1.1. China Carotid Artery Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.3.1.2. Market Dynamics

8.3.1.3. Competitive Landscape

8.3.1.4. Regulatory Framework

8.3.1.5. Reimbursement Scenario

8.3.2. Japan

8.3.2.1. Japan Carotid Artery Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.3.2.2. Market Dynamics

8.3.2.3. Competitive Landscape

8.3.2.4. Regulatory Framework

8.3.2.5. Reimbursement Scenario

8.3.3. India

8.3.3.1. India Carotid Artery Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.3.3.2. Market Dynamics

8.3.3.3. Competitive Landscape

8.3.3.4. Regulatory Framework

8.3.3.5. Reimbursement Scenario

8.3.4. Australia

8.3.4.1. Australia Carotid Artery Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.3.4.2. Market Dynamics

8.3.4.3. Competitive Landscape

8.3.4.4. Regulatory Framework

8.3.4.5. Reimbursement Scenario

8.3.5. South Korea

8.3.5.1. South Korea Carotid Artery Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.3.5.2. Market Dynamics

8.3.5.3. Competitive Landscape

8.3.5.4. Regulatory Framework

8.3.5.5. Reimbursement Scenario

8.3.6. Thailand

8.3.6.1. Thailand Carotid Artery Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.3.6.2. Market Dynamics

8.3.6.3. Competitive Landscape

8.3.6.4. Regulatory Framework

8.3.6.5. Reimbursement Scenario

8.3.7. Indonesia

8.3.7.1. Indonesia Carotid Artery Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.3.7.2. Market Dynamics

8.3.7.3. Competitive Landscape

8.3.7.4. Regulatory Framework

8.3.7.5. Reimbursement Scenario

8.3.8. Rest of Asia Pacific

8.3.8.1. Rest of Asia Pacific Carotid Artery Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.3.8.2. Market Dynamics

8.3.8.3. Competitive Landscape

8.3.8.4. Regulatory Framework

8.3.8.5. Reimbursement Scenario

8.4. Latin America

8.4.1. Brazil

8.4.1.1. Brazil Carotid Artery Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.4.1.2. Market Dynamics

8.4.1.3. Competitive Landscape

8.4.1.4. Regulatory Framework

8.4.1.5. Reimbursement Scenario

8.4.2. Mexico

8.4.2.1. Mexico Carotid Artery Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.4.2.2. Market Dynamics

8.4.2.3. Competitive Landscape

8.4.2.4. Regulatory Framework

8.4.2.5. Reimbursement Scenario

8.4.3. Argentina

8.4.3.1. Argentina Carotid Artery Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.4.3.2. Market Dynamics

8.4.3.3. Competitive Landscape

8.4.3.4. Regulatory Framework

8.4.3.5. Reimbursement Scenario

8.4.4. Colombia

8.4.4.1. Colombia Carotid Artery Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.4.4.2. Market Dynamics

8.4.4.3. Competitive Landscape

8.4.4.4. Regulatory Framework

8.4.4.5. Reimbursement Scenario

8.5. Middle East and Africa

8.5.1. South Africa

8.5.1.1. South Africa Carotid Artery Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.5.1.2. Market Dynamics

8.5.1.3. Competitive Landscape

8.5.1.4. Regulatory Framework

8.5.1.5. Reimbursement Scenario

8.5.2. Saudi Arabia

8.5.2.1. Saudi Arabia Carotid Artery Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.5.2.2. Market Dynamics

8.5.2.3. Competitive Landscape

8.5.2.4. Regulatory Framework

8.5.2.5. Reimbursement Scenario

8.5.3. UAE

8.5.3.1. UAE Carotid Artery Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.5.3.2. Market Dynamics

8.5.3.3. Competitive Landscape

8.5.3.4. Regulatory Framework

8.5.3.5. Reimbursement Scenario

8.5.4. Kuwait

8.5.4.1. Kuwait Carotid Artery Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.5.4.2. Market Dynamics

8.5.4.3. Competitive Landscape

8.5.4.4. Regulatory Framework

8.5.4.5. Reimbursement Scenario

8.5.5. Rest of Middle East and Africa

8.5.5.1. Rest of MEA Carotid Artery Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.5.5.2. Market Dynamics

8.5.5.3. Competitive Landscape

8.5.5.4. Regulatory Framework

8.5.5.5. Reimbursement Scenario

9. Competitive Landscape

9.1. Company Market Share Analysis, 2025

9.2. Company Tier Structure

9.3. List of Major Suppliers, By Key Countries

9.4. Key Company Positioning Analysis

9.5. Company Profile

9.5.1. Abbott Laboratories

9.5.2. AngioDynamics, Inc.

9.5.3. Balton Sp. z o.o.

9.5.4. Biotronik SE & Co. KG

9.5.5. Boston Scientific Corporation

9.5.6. Cardinal Health, Inc.

9.5.7. Cook Medical Inc.

9.5.8. Cordis

9.5.9. C.R. Bard, Inc.

9.5.10. DISA Vascular

9.5.11. Gore Medical (W. L. Gore & Associates, Inc.)

9.5.12. InspireMD, Inc.

9.5.13. Lifetech Scientific Corporation

9.5.14. Medtronic plc

9.5.15. Merit Medical Systems, Inc.

9.5.16. MicroPort Scientific Corporation

9.5.17. Optimed Medizinische Instrumente GmbH

9.5.18. Roxwood Medical, Inc.

9.6. Key Development Strategies

9.6.1. New Product Launches

9.6.2. Mergers and Acquisition

9.6.3. Partnerships and Collaborations

9.6.4. Expansion Plans

10. Analyst Perspective

11. Related Reports

Related Research

Global Hyaluronic Acid-Based Dermal Fillers Market Size, Share, and Industry Analysis- by Product Type, by Gender, by Elasticity Module, by Application, and by End-use, Growth and Trend Forecast, 2026 – 2035

April 23, 2026View

Global Non-invasive Fat Reduction Market Size, Share, and Industry Forecast – by Product Type, by Application, by Gender, and by End-use- Growth and Forecast, 2026- 2035

April 23, 2026View

Global Wound Care Market Size, Share, and Industry Analysis – by Product Type, by Wound Type, and by End-use – Growth and Trend Forecast, 2026 -2035

April 22, 2026View

Revolution Insights Briefs

Stay informed with updates on related market reports and key industry topics.